Design and synthesis of novel benzopyran-2-one derivatives of expected antimicrobial activity through DNA gyrase-B inhibition

Archiv der Pharmazie

Volumn 341, Issue 11, 2008, Pages 725-733

  Hassan, Ghaneya S ^a   Farag, Nahla A ^a   Hegazy, Gehan Hegazy ^a   Arafa, Reem K ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

2H benzopyran 2 one; Antimicrobial activity; Coumarin; DNA gyrase B inhibitor; Molecular modeling

Indexed keywords

BENZOPYRAN DERIVATIVE; COUMARIN DERIVATIVE; DNA TOPOISOMERASE (ATP HYDROLYSING) B; GYRASE INHIBITOR;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; DRUG DESIGN; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MOLECULAR DOCKING; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CANDIDA ALBICANS; COMPUTER SIMULATION; COUMARINS; DNA GYRASE; DRUG DESIGN; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MODELS, MOLECULAR; PROTEIN BINDING;

EID: 57349173606     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200700266     Document Type: Article

References (24)

1. R. Menzel, M. Gellert, Adv. Pharmacol. 1994, 29A, 201-225.
2. A. Maxwell, M. Gellert, Adv. Protein Chem. 1986, 38, 69-107.
3. S. C. Kampranis, A. D. Bates, A. Maxwell, Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 8414-8419.
4. L. Brino, A. Urzhumtsev, M. Mousli, C. Bronner, et al., J. Biol. Chem. 2000, 275, 9468-9475.
5. R. H. Flatman, A. Eustaquio, S. M. Li, L. Heide, A. Maxwell, Antimicrob Agents Chemother. 2006, 50, 1136-1142.
6. A. Maxwell, Trends Microbiol 1997, 5, 102-109.
7. F. Broccolo, G. Cainelli, G. Caltabiano, C. E. Cocuzza, et al., J. Med. Chem. 2006, 49, 2804-2811.
8. F. Benfatti, G. Cardillo, L. Gentilucci, A. Tolomelli, Bioorg. Med. Chem. Lett. 2007, 17, 1946-1950.
9. M. Cherry, C. G. Daly, D. Mitchell, J. Highfield, J. Clin. Periodontol. 2007, 34, 148-155.
10. M. E. Hensler, G. Bernstein, V. Nizet, A. Nefzi, Bioorg. Med. Chem. Lett. 2006, 16, 5073-5079.
11. A. I. Eid, F. A. Ragab, S. L. El-Ansary, S. M. El-Gazayerly, F. E. Mourad, Arch. Pharm. 1994, 327, 211-213.
12. A. A. Farghaly, P. Vanelle, H. S. El-Kashef, Heterocycl. Comm. 2005, 11, 255-262.
13. M. Cacic, M. Trkovnik, F. Cacic, E. Has-Schon, Molecules 2006, 11, 134-147.
14. M. Sayyed, S. Mokle, M. Bokhare, A. Mankar, et al., ARKIVOC 2006, ii, 187-192.
15. R. P. Tomko, C. B. Johansson, M. Totrov, R. Abagyan, et al., Exp. Cell Res. 2000, 255, 47-55.
16. I. Kufareya, L. Budagyan, E. Raush, M. Totrov, R. Abagyan, Proteins 2007, 67, 400-417.
17. C. N. Cavasotto, M. A. Ortiz, R. A. Abagyan, F. J. Piedrafita, Bioorg. Med. Chem. Lett. 2006, 16, 1969-1974.
18. A. S. Hamed, S. L. El-Ansary, D. A. Abou El-Ella, N. A. Farag, Bull. Fac. Pharm. Cairo Univ. 2005, 43, 73-86.
19. A. K. Bose, Y. H. Chlang, M. S. Manhas, Tetrahedron Lett. 1972, 40, 4091-4094.
20. C. H. Collins, Microbiol. Methods (Butterworths: London) 1967, 364.
21. D. A. Ostrov, J. A. Hemández Parda, P. E. Corsino, K. A. Finton, T. C. Le N. Rowe, Antimicrob Agents Chemother. 2007, 51, 3688-3698.
22. M. Oblak, S. G. Grdadolink, M. Kotnik, R. Jerala, et al., Bioorg. Med. Chem. Lett. 2005, 15, 5207-5210.
23. H. J. Boehm, M. Boehringer, D. Bur, H. Gmuender, et al., J. Med. Chem. 2000, 43, 2664-2674.
24. G. A. Holdgate, A. Tunnicliffe, W. H. Ward, S. A. Weston, et al., Biochemistry 1997, 36, 9663-9673.